secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001193125-24-154364
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences updates corporate deck for Jefferies conference; no material new data
--------------------------------------------------------------------------------

- Company conducting investor meetings at Jefferies Global Healthcare Conference starting June 5, 2024.
- Updated corporate presentation filed as Exhibit 99.1; no specific financial or clinical updates disclosed.
- No changes to guidance, pipeline milestones, or regulatory timelines announced.
- Presentation includes forward-looking statements referencing risks in prior SEC filings.
- Event is routine conference participation; no earnings or business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524154364/0001193125-24-154364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524154364/d846290d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer